Comparison

Anti-Human Hepsin (Clone 2D5) – Purified - 200 µg

Item no. LEIN-H4410-200ug
Manufacturer Leinco Technologies
Amount 200 ug
Quantity options 100 ug 200 ug 50 ug
Category
Type Antibody Monoclonal
Applications WB, FC, ELISA
Clone 2D5
Specific against Human (Homo sapiens)
Host Mouse
NCBI 3249
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Shipping Condition Cool pack
Available
Manufacturer - Applications
Quality Tested by Leinco ELISA
FC
WB
Manufacturer - Category
Primary Monoclonal Antibodies>Cell Proliferation Markers|Primary Monoclonal Antibodies>SurfaceTag Human CD Markers
Manufacturer - Targets
Hepsin
Country of Origin
USA
Shipping Temperature
Next Day 2 - 8°C
Storage Conditions
This purified antibody is stable when stored at 2-8°C. Do not freeze.
Product Description
Hepsin is a type II transmembrane serine protease (TTSP) expressed on the surface of epithelial cells including the liver, kidney, prostate, and thyroid in human tissues. The physiological function of hepsin is unclear, although, In vitro studies have shown that hepsin activates blood clotting factors VII, XII, and IX, pro-urokinase (pro-uPA), and pro-hepatocyte growth factor (pro-HGF). The over-expression of hepsin has been implicated in several types of cancer, especially ovarian and prostate, which makes it an attractive diagnostic marker for cancers. Most notably, hepsin has been identified as one of the most highly induced genes in prostate cancer, and this over-expression is correlated with the cancer progression and metastasis. Furthermore anti-hepsin antibodies have been shown to inhibit the invasion of human prostate cancer cells.1
Background
Hepsin is a type II transmembrane serine protease (TTSP) expressed on the surface of epithelial cells including the liver, kidney, prostate, and thyroid in human tissues. The physiological function of hepsin is unclear, although, In vitro studies have shown that hepsin activates blood clotting factors VII, XII, and IX, pro-urokinase (pro-uPA), and pro-hepatocyte growth factor (pro-HGF). The over-expression of hepsin has been implicated in several types of cancer, especially ovarian and prostate, which makes it an attractive diagnostic marker for cancers. Most notably, hepsin has been identified as one of the most highly induced genes in prostate cancer, and this over-expression is correlated with the cancer progression and metastasis. Furthermore anti-hepsin antibodies have been shown to inhibit the invasion of human prostate cancer cells.1
PubMed
Hepsin
Manufacturer - Research Area
Immuno-Oncology
Manufacturer - Specificity
Clone 2D5 recognizes Human hepsin. It binds to a separate epitope than clone 3H10.1. These clones do not interfere with one another.
RRID
AB_2830334
Concentration
0.5 mg/ml
Formulation
This purified antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Antigen Distribution
Hepsin is expressed on the surface of epithelial cells including the liver, kidney, prostate, and thyroid in human tissues.
Immunogen
Human hepsin protein
Additional Information
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Keywords
Anti-HEPSIN monoclonal antibodies, HPN, TMPRSS1, Hepsin Antibody, Monoclonal Anti-HPN antibody produced in mouse, 2D5-1.9, 2D5.1.9

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close